Your browser doesn't support javascript.
loading
ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update.
Schieda, Nicola; Oto, Aytekin; Allen, Brian C; Akin, Oguz; Barker, Samantha J; Fulgham, Pat F; Gettle, Lori Mankowski; Maranchie, Jodi K; Patel, Bhavik N; Schuster, David M; Smith, Dan; Turkbey, Ismail B; Lockhart, Mark E.
Afiliación
  • Schieda N; Ottawa Hospital Research Institute and the Department of Radiology, The University of Ottawa, Ottawa, Ontario, Canada. Electronic address: nschieda@toh.ca.
  • Oto A; Panel Chair, University of Chicago, Chicago, Illinois.
  • Allen BC; Panel Vice-Chair, Duke University Medical Center, Durham, North Carolina.
  • Akin O; Memorial Sloan Kettering Cancer Center, New York, New York; Director of Body MRI.
  • Barker SJ; University of Minnesota, Minneapolis, Minnesota; Director of Body Ultrasound M Health Fairview.
  • Fulgham PF; Urology Clinics of North Texas, Dallas, Texas; American Urological Association; Chairman of the Department of Urology, Texas Health Presbyterian Hospital of Dallas.
  • Gettle LM; University of Wisconsin, Madison, Wisconsin.
  • Maranchie JK; UPMC, Pittsburgh, Pennsylvania; American Urological Association.
  • Patel BN; Stanford University Medical Center, Stanford, California; Director of AI.
  • Schuster DM; Emory University Hospital, Atlanta, Georgia.
  • Smith D; The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada, Primary care physician.
  • Turkbey IB; National Institutes of Health, Bethesda, Maryland; Staff Clinician at NIH.
  • Lockhart ME; Specialty Chair, University of Alabama at Birmingham, Birmingham, Alabama; Chair, ACR Appropriateness Committee.
J Am Coll Radiol ; 19(5S): S194-S207, 2022 05.
Article en En | MEDLINE | ID: mdl-35550802
The staging and surveillance of testicular cancer is a complex topic, which integrates clinical, biochemical, and imaging components. The use of imaging for staging and surveillance of testicular cancer is individually tailored to each patient by considering tumor histology and prognosis. This document discusses the rationale for use of imaging by imaging modality during the initial staging of testicular seminoma and nonseminoma tumors and during the planned surveillance of stage IA and IB testicular cancer by histological subtype integrating clinical suspicion for disease recurrence in surveillance protocols. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Testiculares Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans / Male País/Región como asunto: America do norte Idioma: En Revista: J Am Coll Radiol Asunto de la revista: RADIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Testiculares Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Límite: Humans / Male País/Región como asunto: America do norte Idioma: En Revista: J Am Coll Radiol Asunto de la revista: RADIOLOGIA Año: 2022 Tipo del documento: Article